- Home
- IBTA vs TXG Comparison
IBTA vs TXG Comparison
Compare IBTA & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBTA
- TXG
- Stock Information
- Founded
- IBTA 2011
- TXG 2012
- Country
- IBTA United States
- TXG United States
- Employees
- IBTA N/A
- TXG N/A
- Industry
- IBTA
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- IBTA
- TXG Industrials
- Exchange
- IBTA Nasdaq
- TXG Nasdaq
- Market Cap
- IBTA 1.1B
- TXG 1.3B
- IPO Year
- IBTA 2024
- TXG 2019
- Fundamental
- Price
- IBTA $36.47
- TXG $13.01
- Analyst Decision
- IBTA Buy
- TXG Buy
- Analyst Count
- IBTA 10
- TXG 14
- Target Price
- IBTA $74.60
- TXG $14.96
- AVG Volume (30 Days)
- IBTA 367.6K
- TXG 4.6M
- Earning Date
- IBTA 08-12-2025
- TXG 08-07-2025
- Dividend Yield
- IBTA N/A
- TXG N/A
- EPS Growth
- IBTA 24.66
- TXG N/A
- EPS
- IBTA 2.03
- TXG N/A
- Revenue
- IBTA $369,501,000.00
- TXG $624,662,000.00
- Revenue This Year
- IBTA $6.89
- TXG N/A
- Revenue Next Year
- IBTA $15.55
- TXG $6.06
- P/E Ratio
- IBTA $17.93
- TXG N/A
- Revenue Growth
- IBTA 7.20
- TXG N/A
- 52 Week Low
- IBTA $31.40
- TXG $6.78
- 52 Week High
- IBTA $79.80
- TXG $24.76
- Technical
- Relative Strength Index (RSI)
- IBTA N/A
- TXG 77.05
- Support Level
- IBTA N/A
- TXG $11.25
- Resistance Level
- IBTA N/A
- TXG $12.11
- Average True Range (ATR)
- IBTA 0.00
- TXG 0.70
- MACD
- IBTA 0.00
- TXG 0.17
- Stochastic Oscillator
- IBTA 0.00
- TXG 95.62
About IBTA Ibotta Inc. Class A Common Stock
Ibotta Inc is a performance marketing platform. It allows CPG brands to deliver digital promotions to consumers through a single, convenient network called the Ibotta Performance Network (IPN).
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).